Going There with Dr. Mike Marcus King on Over-Communicating and Advocating for Psychiatric Care
To wrap up Mental Health Awareness Month, singer-songwriter Marcus King joins Going There with Dr. Mike for and honest, open conversation. Listen to the artist talk about his experience with being bipolar, his coping strategies, and more.
King talks with Dr. Mike about his battle with feelings of "terrible hopelessness" in regards to his life and the world, detailing the ways he identifies such feelings and how he combats them. To that point, the artist explains how important it was for him to develop a vocabulary to address his mental health, one that allows him to adequately describe what he's going through to others
Listen to Marcus King chat about all of this and more in the new episode of Going There with Dr. Mike. Marcus King also has a new album out, Mood Swings, and is in the midst of an international tour as part of Chris Stapleton’s "All-American Road Show." Get tickets here.
Then make sure to like, review, and subscribe to the show, presented by the Consequence Podcast Network and Sound Mind Live, wherever you get your podcasts.
Season 5 of Going There with Dr. Mike is brought to you by Johnson & Johnson who believes that health is everything. Their strength in healthcare innovation empowers them to build a world where complex diseases are prevented, treated, and cured, where treatments are smarter and less invasive, and solutions are personal. Through their expertise in Innovative Medicine and MedTech, they are uniquely positioned to innovate across the full spectrum of healthcare solutions today to deliver the breakthroughs of tomorrow, and profoundly impact health for humanity. Learn more at www.jnj.com @JanssenUS and @JNJInnovMed on Twitter.
This season is also brought to you by AbbVie, who is driving the pursuit of better mental health. Over the last 30 years, AbbVie’s scientists and clinicians have worked to tackle the complexity of mental illness and today offer a portfolio of medicines and a pipeline of innovation that spans depression, anxiety, bipolar 1 disorder, and schizophrenia. To learn more about AbbVie’s work to support individuals throughout their mental health journey, please visit www.AbbVie.com or follow at AbbVie on Twitter, Facebook, Instagram, YouTube, and LinkedIn.
This episode is also brought to you by Alkermes. Alkermes is a global biopharmaceutical company developing innovative medicines in the field of neuroscience with products that treat alcohol dependence, opioid dependence, schizophrenia, and bipolar I disorder. To learn more, please visit Alkermes' website at www dot AL-ker-mees dot com or follow at Alkermes on Twitter and LinkedIn.